The Gross Margin of Hansa Biopharma AB (HNSA.ST) is 51.23%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 51.23% |
| 2023-12-31 | 52.91% |
| 2022-12-31 | 75.10% |
| 2021-12-31 | 54.47% |
| 2020-12-31 | 83.65% |
| 2019-12-31 | 74.26% |
| 2018-12-31 | 72.72% |
| 2017-12-31 | 93.58% |
| 2016-12-31 | 91.59% |
| 2015-12-31 | 90.14% |